Medtronic says it will spend more than three and a half BILLION dollars to get into the diabetes (die-ah-BEE-tees) treatment business. The Fridley-based medical device giant is buying "MiniMed, Incorporated," a maker of insulin pumps and glucose monitors AND the much smaller -- "Medical Research Group," which is developing an implantable insulin system. Medtronic says with the two Los Angeles-based companies it can begin serving the enormous and rapidly-growing diabetes market. Minnesota Public Radio's Mark Zdechlik reports...
Views and opinions expressed in the content do not represent the opinions of APMG. APMG is not responsible for objectionable content and language represented on the site. Please use the “Contact Us” button if you’d like to report a piece of content. Thank you.
Transcriptions provided are machine generated, and while APMG makes the best effort for accuracy, mistakes will happen. Please excuse these errors and use the “Contact Us” button if you’d like to report an error. Thank you.